Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1166.45
-9.10 (-0.77%)
< Home < Back

Dr. Reddy's enters into exclusive sales and distribution agreement with Novartis India

Date: 12-02-2022

Dr. Reddy's Laboratories has entered into an exclusive sales and distribution agreement with Novartis India (NIL) for the Voveran range, the Calcium range and Methergine in India.

Under the arrangement, Dr. Reddy’s will have exclusive rights to promote and distribute the well-established Voveran range, the Calcium range and Methergine in India. The company will use its strengths in promotion and distribution to considerably expand its engagement with healthcare professionals with the aim of enabling access to patients in need.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.